Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J Clin Med ; 12(22)2023 Nov 09.
Artículo en Inglés | MEDLINE | ID: mdl-38002621

RESUMEN

Newer management strategies are being evaluated to treat obesity, which continues to increase worldwide. After 12 h of fasting, the body switches from glucose to fat metabolism, regulating protein synthesis and autophagy. These cellular responses are central to the metabolic benefits of time-restricted eating (TRE), independent of calorie restriction and weight loss, and they have heightened interest in TRE regimens. Controversy remains, however, regarding the benefits of TRE regimens. We reviewed the current literature and concluded that TRE is equivalent to calorie restriction for weight loss and has positive effects for patients with diseases such as nonalcoholic fatty liver disease, cancer, and cardiovascular disease.

2.
Am J Med ; 132(6): 678-684, 2019 06.
Artículo en Inglés | MEDLINE | ID: mdl-30710538

RESUMEN

Depression continues to be a challenging condition to treat despite the myriad treatment options available. Primary care providers are increasingly tasked with providing second- and third-line treatments for major depressive disorder, and thus, should be familiar with newer medication therapies that are available. In this article, we aim to provide the general internist and other providers who treat depression in their practice with a succinct review of recent developments in the treatment of depression.


Asunto(s)
Antidepresivos/uso terapéutico , Depresión/tratamiento farmacológico , Aprobación de Drogas , Humanos
3.
J Eval Clin Pract ; 13(3): 321-5, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17518794

RESUMEN

RATIONALE, AIMS AND OBJECTIVES: Advances in medicine have led to a multitude of diagnostic tests. The contribution of the clinical skills of the general internist in the context of all these advances is unknown. Our objective was to assess the relative contributions of clinical skills and diagnostic test results in arriving at a final diagnosis. METHODS: Records were retrospectively reviewed from 248 consecutive patients admitted to a general internal medicine hospital service during a 3-month period in 2000. All diagnostic evaluations that yielded the final diagnosis were recorded along with the date and time they were performed. Diagnostic credit was given to the evaluation that yielded the diagnosis at the earliest point in time. RESULTS: All cases had a firm diagnosis by 3 months after hospitalization. Of the 248 patients, 246 received a final diagnosis during hospitalization. The diagnoses were made by use of the clinical judgement of the general internist in 50.4% of the cases, a radiologic study in 31.7%, a blood test or culture result in 9.4%, biopsy findings in 3.3% and various other diagnostic studies (endoscopy, echocardiography, electromyography and electroencephalography) in 5.2%. Clinicians provided the correct diagnosis significantly more often than radiologic studies (P = 0.0015), which was the next most useful type of diagnostic evaluation. CONCLUSION: Although technology has become increasingly available in clinical practice, clinical expertise and skills are still important factors with respect to making correct, timely diagnoses in hospitalized patients.


Asunto(s)
Competencia Clínica , Diagnóstico Diferencial , Pruebas Diagnósticas de Rutina , Humanos , Auditoría Médica , Estudios Retrospectivos , Estados Unidos
4.
Cleve Clin J Med ; 84(12): 951-958, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29244650

RESUMEN

Weight-loss drugs are being evaluated for their role in obesity management. This article reviews the available weight-loss drugs, their efficacy and side effects, and their best clinical use.


Asunto(s)
Fármacos Antiobesidad/uso terapéutico , Obesidad/tratamiento farmacológico , Adulto , Depresores del Apetito/uso terapéutico , Benzazepinas/uso terapéutico , Bupropión/uso terapéutico , Combinación de Medicamentos , Humanos , Lactonas/uso terapéutico , Liraglutida/uso terapéutico , Naltrexona/uso terapéutico , Orlistat , Fentermina/uso terapéutico
5.
Am J Med ; 133(4): e161, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-32331574
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA